A dietary supplement used to build muscle – or prevent muscle loss as a result of ageing or illness – is to be trialled as a potential treatment for chronic liver disease.
Key Takeaways Akero Therapeutics shares traded near their all-time high as the drugmaker reported positive results in a study of its treatment for liver disease.The drug, known as EFX, helped reverse ...
"Patients with MASH-related cirrhosis have extremely limited treatment options ... had similar characteristics such as severity of liver disease at their baseline liver biopsy.